What is Xtant Medical Holdings's G&A?

Xtant Medical Holdings (XTNT) reported G&A of $6.27M in Q1 2026.

How has Xtant Medical Holdings's G&A changed year-over-year?

Xtant Medical Holdings's G&A decreased by 16.7% year-over-year, from $7.53M to $6.27M.

What is the long-term trend for Xtant Medical Holdings's G&A?

Over 4 years (2021 to 2025), Xtant Medical Holdings's G&A has grown at a 19.4% compound annual growth rate (CAGR), from $14.45M to $29.38M.

Overhead costs not directly tied to production or sales — corporate management, legal, accounting, office rent, insurance, and other administrative functions.

Xtant Medical Holdings XTNT G&A

G&A at other companies

SI-BONE, Inc.SIBN

$10.04M+0.8%

CONMEDCNMD

$32.4M-0.8%

LeMaitre VascularLMAT

$12.05M+14.9%

OrthoPediatricsKIDS

$31.02M+2.5%

Other financials

Income statement

See full

Revenue$20.9M-36.5%

Gross profit$12.0M-40.9%

Operating income-$2.9M-375%

Net income-$3.1M-5,426%

EPS (diluted)-$0.02—

Balance sheet

See full

Cash & equivalents$12.2M+124%

Total debt$15.0M-34.9%

Total equity$48.6M+10.8%

Total assets$78.0M-18.6%

Cash flow

See full

Operating cash flow-$2.1M-265%

CapEx$194.0K-83.7%

Free cash flow-$2.3M-2,753%

Valuation

See full

Market cap$59.05M-32.5%

Enterprise value$61.89M-41.5%

P/E32.3×—

P/S0.5×-0.2×

Profitability

See full

Gross margin62.3%+4.2pp

Operating margin4.8%+2.8pp

Net margin1.5%+0.8pp

FCF margin6.4%+4.1pp

Returns & leverage

See full

Return on equity3.9%+2.1pp

Debt / equity0.3×-0.2×

Current ratio3.3×+1.0×

Where this comes from

Reported directly by Xtant Medical Holdings in its filing.

Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.

The official record: Xtant Medical Holdings’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Xtant Medical Holdings's g&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Xtant Medical Holdings's G&A?: Xtant Medical Holdings (XTNT) reported G&A of $6.27M in Q1 2026.
How has Xtant Medical Holdings's G&A changed year-over-year?: Xtant Medical Holdings's G&A decreased by 16.7% year-over-year, from $7.53M to $6.27M.
What is the long-term trend for Xtant Medical Holdings's G&A?: Over 4 years (2021 to 2025), Xtant Medical Holdings's G&A has grown at a 19.4% compound annual growth rate (CAGR), from $14.45M to $29.38M.
What does G&A mean?: Overhead costs not directly tied to production or sales — corporate management, legal, accounting, office rent, insurance, and other administrative functions.